AFP DEPARTMENT COLLECTION
Implementing AHRQ Effective Health Care Reviews
This department provides concise summaries of the AHRQ’s comparative effectiveness reviews, produced by their Effective Health Care Program, including key evidence-based conclusions and practice pointers to put the evidence into clinical perspective.
Oct 1, 2014 Issue
Effectiveness of Outpatient Case Management for Adults
Does outpatient case management for adults with medical illness and complex care needs improve patient-centered outcomes, quality of care, or resource utilization?
May 1, 2014 Issue
Acute Migraine Treatment in Emergency Settings
What are the comparative benefits and adverse effects of parenteral treatments for adults who present to the emergency department with migraine headaches?
Mar 15, 2014 Issue
Preventing Recurrent Nephrolithiasis in Adults
What are the potential benefits and adverse effects associated with dietary and pharmacologic interventions to prevent recurrence of kidney stones in adults 18 years and older?
Nov 15, 2013 Issue
Second-Generation Antidepressants for Depression in Adults
What are the comparative effectiveness and adverse effects of second-generation antidepressants for treating depression in adults?
Aug 15, 2013 Issue
ADHD Interventions in Children Younger Than Six Years
What are the potential benefits and adverse effects associated with treatments for attention-deficit/hyperactivity disorder (ADHD) in preschool-aged children (younger than six years)?
May 15, 2013 Issue
Treatments for Urinary Incontinence in Women
What are the effectiveness, benefits, and adverse effects of options for diagnosis and treatment of urinary incontinence (UI) that are available in primary care?
Oct 1, 2012 Issue
Managing Chronic Gastroesophageal Reflux Disease
What are the effectiveness, benefits, and harms of therapies used to address symptoms and prevent adverse long-term outcomes in adults with gastroesophageal reflux disease (GERD)?
Jul 1, 2012 Issue
Adding ACE Inhibitors or ARBs to Standard Therapy for Stable Ischemic Heart Disease
Are there clinical advantages to augmenting standard therapy for stable ischemic heart disease with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)?